Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 9,163 for bone marrow diseases online drugs. (0.22 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
Drug For Multiple Myeloma Demonstrated To Significantly Extend ...
18 Dec 2009
18, 2009-Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) ... The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at: <www.nhlbi.nih.gov>. ...
Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html
[ More results from Drugs.com - Clinical Trials ]

PAXALLES: DRUG FOR MULTIPLE MYELOMA DEMONSTRATED TO SIGNIFICANTLY ...
18 Dec 2009 by CA Morrison  
DRUG FOR MULTIPLE MYELOMA DEMONSTRATED TO SIGNIFICANTLY EXTEND DISEASE-FREE SURVIVAL. Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who .... The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at: <www.nhlbi.nih.gov>. ...
PAXALLES - http://paxalles.blogs.com/paxalles/

Drug for Multiple Myeloma Demonstrated to Significantly Extend ...
18 Dec 2009 by Yahoo! News Search Results for Multiple Myeloma  
Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following ...
Feed - http://www.myelomaforums.com/
[ More results from Feed ]

Bone Marrow Transplants May Cure Sickle Cell in Adults - KFDA ...
10 Dec 2009
The last item is important, because in conventional bone marrow transplants, high doses of chemotherapy drugs and radiation typically destroy fertility. However, the lower level of radiation used in the new method does not seem to do this. ... Conventional bone marrow transplants cure sickle cell disease by first using chemotherapy and radiation to wipe out the person's own marrow, which makes the faulty red blood cells. The marrow is replaced with stem cells from a ...
KFDA - Health Watch - http://www.newschannel10.com/global/category.asp?c=73756

CRWESelect Hot Stock Alerts Dec. 18, 2009 CRWE, PWRM, CSRH, CVAT ...
18 Dec 2009 by admin  
However, the company has re-focused its primary vision to that of an online media advertising/awareness publisher, focused on serving the needs of the clients, as well as being dedicated to the distribution of quality branding information. .... The final topic covered was the discovery of biomarkers in bone marrow cells from chronic myelogenous leukemia patients that predict whether they would respond to the drug imatinib mesylate (Gleevec). “Power3 has begun confidential ...
CRWE Select - http://crweselect.com/

Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in ...
10 Dec 2009 by insciences  
In trials by other investigators, nearly 200 children with severe sickle cell disease were cured with bone marrow transplants after undergoing a regimen in which their own marrow was completely destroyed with chemotherapy. ... To achieve this goal, the investigators used a low dose of radiation to the whole body and two drugs, alemtuzumab and sirolimus, to suppress the immune system. Alemtuzumab depletes immune cells, but does not adversely affect blood stem cells. ...
Articles - http://insciences.org/articles.php
[ More results from Articles ]

Pfizer And Protalix Enter Into Agreement To Develop And Commerci
1 Dec 2009
As a result, lipid engorged cells (called Gaucher cells) amass in different parts of the body, primarily the spleen, liver and bone marrow. Accumulation of Gaucher cells may cause spleen and liver enlargement, anemia, excessive bleeding and ... Protalix is also advancing additional recombinant biopharmaceutical drug development programs. Taliglucerase alfa is an enzyme replacement therapy in development under a Special Protocol Assessment with FDA for Gaucher's disease. ...
Pharmaceutical Online News - http://www.pharmaceuticalonline.com/
[ More results from Pharmaceutical Online News ]

The cost of care : Deludia
13 hours ago by bk  
All profound disease has a terrible cost. After all, a life is being extinguished in slow motion right in front of God and everyone. But it is important to understand that the people who care for the sick can, if we aren't very careful and caring ... Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) ...
Deludia - http://www.deludia.com/
[ More results from Deludia ]

Stock-PR.com Reporting CRWE, CSRH, CVAT, MPPC, PWRM, TAXS, HCEI ...
17 Dec 2009 by WooEB  
MPPC is a web-based online provider of digital photo processing, photo finishing, photo sharing, and related services. The Company's unique blend of 1000 print options, combined with manual print inspections and professional color management, have positioned ... The final topic covered was the discovery of biomarkers in bone marrow cells from chronic myelogenous leukemia patients that predict whether they would respond to the drug imatinib mesylate (Gleevec). ...
WooEB Blog - http://blogs.wooeb.com/
[ More results from WooEB Blog ]

St. Jude researchers present at American Society of Hematology's ...
8 Dec 2009
Shih-Hsiang Chen, MD, described efforts to identify genetic variations that leave patients at increased risk for an allergic reaction to a key anti-leukemia drug. The drug, asparaginase, is widely used in ALL treatment of ALL. The drug triggers an allergic .... Hiroto Inaba, MD, PhD, Oncology, outlined evidence that certain bone marrow transplant patients should be closely monitored for common childhood diseases even despite being re-vaccinated following the transplant. ...
St. Jude Children's Research Hospital -... - http://www.stjude.org/stjude/v/index.jsp?vgnextoid=f...

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google